ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1367 • 2015 ACR/ARHP Annual Meeting

    Fibroblast-like Synoviocytes Shape and Perpetuate the Inflammatory Immune Responses Associated with Antibiotic-Refractory Lyme Arthritis.

    Klemen Strle1, Robert Locchead2, Annalisa Pianta3, Jameson T. Crowley3, Sheila Arvikar1 and John Aversa4, 1Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2Rheumatology, Allery and Immunology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 3Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Yale Medical Group, Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, CT

    Background/Purpose: Antibiotic-refractory Lyme arthritis is defined as persistent synovitis for months to years after antibiotic therapy for Borrelia burgdorferi, the causative agent of Lyme disease.…
  • Abstract Number: 1368 • 2015 ACR/ARHP Annual Meeting

    PMN Reactivity Contribute to Acute Onset Joint Inflammation By Increasing CXCL8 Production in Joints of RA Patients with Anti-Collagen II Antibodies

    Vivek Anand Manivel1, Azita Sohrabian2 and Johan Rönnelid3,4, 1Immunology, Genetics and Pathology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, 2Department of Immunology Genetics and Pathology,Uppsala University, Uppsala, Sweden, 3Department of Immunology, Genetics and Pathology,Uppsala University, Uppsala, Sweden, 44Unit of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: RA patients with antibodies against collagen type II (CII) have a distinct acute onset RA phenotype, associated with cytokine induction by surface-bound anti-CII IC…
  • Abstract Number: 1369 • 2015 ACR/ARHP Annual Meeting

    Enhanced Myelopoiesis Downstream of Toll-like Receptor 9 Activation Drives a Feed-Forward Inflammatory Response

    Lehn K. Weaver1 and Edward M. Behrens2, 1Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 2Pediatric Rheumatology, Childrens Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Monocytes are myeloid cells important for the initiation of inflammation and have been implicated in the pathogenesis of autoimmunity. Monocytes interact with their environment…
  • Abstract Number: 1370 • 2015 ACR/ARHP Annual Meeting

    CD40/CD40L Pathway Is Associated with Increased Oxidative Burst and Neutrophil Extracellular Traps Release in Behcet´s Disease

    Sandro F. Perazzio1,2, Paulo Vitor Soeiro Pereira3, Alexandre W.S. Souza4, Antonio Condino-Neto3 and Luis Eduardo C. Andrade5, 1Rheumatology Division, Universidade Federal de São Paulo, Sao Paulo, Brazil, 2Fleury Medicine and Health, Sao Paulo, Brazil, 3Immunology, ICB IV - Universidade de São Paulo, São Paulo, Brazil, 4Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 5Immunology Division, Fleury Medicine and Health, São Paulo, Brazil

    Background/Purpose: Previous studies suggested that unknown plasma factors increase oxidative burst in Behçet’s disease (BD), but little is known about neutrophil extracellular traps (NET) formation.…
  • Abstract Number: 1371 • 2015 ACR/ARHP Annual Meeting

    Complement-Mediated Neutrophil Lysis-a Mechanism Promoting Hypercitrullination in Rheumatoid Arthritis?  

    Tal Gazitt1, Christian Lood2, Jeffrey Ledbetter3 and Keith B. Elkon3, 1Rheumatology, University of Washington, Seattle, WA, 2University of Washington, Lund, Sweden, 3Division of Rheumatology, University of Washington, Seattle, WA

    Background/Purpose: Protein citrullination, the post-translational conversion of arginine to citrulline, mediated by peptidylarginine deiminase (PAD) enzymes, is considered a likely mechanism for the stimulation of…
  • Abstract Number: 1372 • 2015 ACR/ARHP Annual Meeting

    Characterization of Synovial Mast Cells in Knee Osteoarthritis: Association with Clinical Parameters

    Badelog J.E. de Lange-Brokaar1, Margreet Kloppenburg1, Stefan Andersen1, Annemarie Dorjee1, Erlangga Yusuf1, Linda van Toorn1, Herman Kroon2, Anne-Marie Zuurmond3, Vedrana Stojanovic-Susulic4, Johan Bloem2, Rob Nelissen5, René E. M. Toes6 and Andreea Ioan-Facsinay1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Radiology, Leiden University Medical Center, Leiden, Netherlands, 3TNO, Leiden, Netherlands, 4Janssen, Pharmaceutical Companies Johnson & Johnson, Springhouse, PA, 5Orthopaedics, Leiden University Medical Center, Leiden, Netherlands, 6Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Synovial inflammation is a common feature of osteoarthritis (OA) and rheumatoid arthritis (RA) patients. Comparative studies indicated that synovitis, measured by histology or imaging,…
  • Abstract Number: 1373 • 2015 ACR/ARHP Annual Meeting

    Epigenetic Mechanisms Contribute to the Lack of LPS-Induced Tolerance in Rheumatoid Arthritis Synovial Fibroblasts

    Kerstin Klein1, Renate E. Gay1, Christoph Kolling2, Adrian Ciurea1, Diego Kyburz1, Beat A. Michel1, Lih-Ling Lin3, Steffen Gay1 and Caroline Ospelt1, 1Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Upper Extremity Dept., Schulthess Clinic Zurich, Zurich, Switzerland, 3Inflammation and Immunology Research Unit, Pfizer, Cambridge, MA

    Background/Purpose: In macrophages, repeated stimulation of Toll-like receptor (TLR) 4 leads to a tolerant state of the cell which protects inflamed tissues from damage. We…
  • Abstract Number: 1374 • 2015 ACR/ARHP Annual Meeting

    Mucosal-Associated Invariant T- Cells Are Decreased and Functionally Immature in Peripheral Blood of Patients with Primary Sjögren Syndrome

    Tatjana Banovic1,2,3, Jing Jing Wang4, Dimitra Beroukas5, Pravin Hissaria6 and Tom Gordon2,6, 1Immunology, Level 3, SA Pathology, Adelaide, Australia, 2Flinders University, Adelaide, Australia, 3Pediatrics, University of Adelaide, Adelaide, Australia, 4Immunology, Flinders University, Adelaide, Australia, 5SA Pathology, Adelaide, Australia, 6Immunology, SA Pathology, Adelaide, Australia

    Background/Purpose: Primary Sjögren Syndrome (pSS) is characterized by organ-specific autoimmune destruction of salivary and lacrimal glands. Patients typically experience debilitating symptoms of dry mouth and…
  • Abstract Number: 1375 • 2015 ACR/ARHP Annual Meeting

    S100A8/A9, a Serum and Imaging Biomarker for Assessing Joint Inflammation and Destruction in Experimental Seronegative Arthritis

    Edwin J. W. Geven1, Shahla Abdolahi-Roodsaz1, Annet Sloetjes1, Marije I. Koenders1, Dirk Föll2, Johannes Roth3, Thomas Vogl3 and Peter L. E. M. van Lent1, 1Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 2Department of Pediatric Rheumatology and Immunology, University of Münster, Münster, Germany, 3Institute of Immunology, University of Münster, Münster, Germany

    Background/Purpose: Seronegative joint diseases such as psoriatic arthritis and juvenile idiopathic arthritis are characterized by the lack of autoantibodies, potent biomarkers used for predicting disease…
  • Abstract Number: 1376 • 2015 ACR/ARHP Annual Meeting

    Presence of the Interferon Signature in Anti-Nuclear Antibody Positive Individuals Prior to the Onset of Systemic Autoimmune Rheumatic Disease

    Joan Wither1, Tony Liu1, Babak Noamani2, Dennisse Bonilla1, Sindhu R. Johnson3, Earl Silverman4, Arthur Bookman1, Larissa Lisnevskaia5 and Carolina Landolt-Marticorena1, 1University Health Network, Toronto, ON, Canada, 2Genetics and developmental biology, University Health Network, Toronto, ON, Canada, 3Toronto Scleroderma Program, Toronto Western Hospital, Mount Sinai Hospital, University of Toronto, University Health Network Pulmonary Hypertension Programme, Toronto, ON, Canada, 4The Hospital for Sick Children, Toronto, ON, Canada, 5Lakeridge Health Services, Oshawa, ON, Canada

    Background/Purpose: Patients with systemic autoimmune rheumatic diseases (SARD) often have a prolonged pre-clinical phase during which they are anti-nuclear antibody (ANA)+ but lack clinical symptoms. …
  • Abstract Number: 1377 • 2015 ACR/ARHP Annual Meeting

    IL-22 Drives the Proliferation and Differentiation of Human Bone Marrow Mesenchymal Stem Cells (MSCs); A Novel Pathway That May Contribute to Aberrant New Bone Formation in Human Spa and Beyond

    Yasser El-Sherbiny1, Ahmed Elzayadi2, Evangelos M. Fragkakis1, Richard Cuthbert1, Thomas Baboolal3, Elena Jones1 and Dennis McGonagle1, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2Obstetrics and Gynaecology, Mansoura University, Egypt, MD, MSc., Mansoura, Egypt, 3PhD, Leeds, United Kingdom

    Background/Purpose: The human spondyloarthropathies (SpA) are associated with single nucleotide polymorphisms (SNPs) in the IL-23 pathway and IL-23/17 axis therapy is effective in SpA.  The…
  • Abstract Number: 1378 • 2015 ACR/ARHP Annual Meeting

    AMP-Activated Protein Kinase As an Anti-Inflammatory Target for Methotrexate

    Cornelia Cudrici1, Amma Agyemang1, Martin Pelletier1, Gregory Steinberg2 and Richard M. Siegel1, 1NIAMS, Immunoregulation Section, Autoimmunity Branch, Bethesda, MD, 2Department of Medicine, Division of Endocrinology,McMaster University, Hamilton, ON, Canada

    Background/Purpose: Methotrexate (MTX) is a first-line medication effective in multiple forms of inflammatory arthritis. The anti-inflammatory effects of MTX are more prolonged than its plasma…
  • Abstract Number: 1379 • 2015 ACR/ARHP Annual Meeting

    High Serum IgG4 Concentration Is a Risk Factor for Relapse in IgG4-Related Disease

    Sho Sendo1, Jun Saegusa1, Akira Onishi2, Ikuko Naka1, Kosaku Tsuda1, Takaichi Okano1, Kengo Akashi1, Soshi Takahashi1, Miwa Nishida1, Keisuke Nishimura1, Yo Ueda1, Yoshinori Kogata3, Goichi Kageyama1, Goh Tsuji4, Shunichi Kumagai5 and Akio Morinobu1, 1Department of Rheumatology, Kobe University Hospital, Kobe, Japan, 2Department for Rheumatology, Kobe University Hospital, Kobe, Japan, 3Department of Clinical Pathology and Immunology, Kobe University Hospital, Kobe, Japan, 4Center for Rheumatic disease, Shinko Hospital, Kobe, Japan, 5Center for Rheumatic Disease, Shinko Hospital, Kobe, Japan

    Background/Purpose: IgG4-related disease (IgG4-RD) is a recently recognized systemic fibro-inflammatory disease of unknown etiology with multi-organ involvement. Although the organ involvement in IgG4-RD usually improve…
  • Abstract Number: 1380 • 2015 ACR/ARHP Annual Meeting

    Characterization of Lymphocytes Subsets in Peripheral Blood of Untreated IgG4-Related Disease Patients

    Aurélie Grados1, Mikael Ebbo1, Christelle Piperoglou2, Matthieu Groh3, Alexis Regent4, Maxime Samson5, Benjamin Terrier6, Nathalie Morel7, Sylvain Audia5, Francois Maurier8, Julie Graveleau9, Mohamed Hamidou10, Amandine Forestier11, Sylvain Palat12, Emanuelle Bernit1, Gilles Kaplanski13, Frederique Retornaz14, Bernard Bonotte5, Catherine Farnarier15, Jean-Robert Harle16, Nathalie Costedoat-Chalumeau7, Frederic Vely17 and Nicolas Schleinitz1, 1Internal Medicine, Aix-Marseille Université, AP-HM, Marseille, France, 2Immunology, CIML, AP-HM, Marseille, France, 3National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 4Service de médecine interne, Hôpital Cochin, Paris, France, 5Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon, France, 6Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Paris, France, 7Internal Medicine Department, Cochin Hospital, “René-Descartes Paris V” University, Paris, France, 8HP Metz Belle Isle Hospital, Department of Internal Medicine, Metz, France, 9Medecine Interne Hotel Dieu Nantes, Nantes, France, 10Internal Medicine Department, Nantes University Hospital, Nantes, France, 11Internal Medicine, Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France, 12Service de Medecine Interne, CHU limoges, Limoges, France, 13Internal Medicine hopital conception, Aix-Marseille Université, Marseille, France, 14Conseil General 13 cellule recherche, Marseille, France, 15Laboratoire d'immunologie, Hopital de la Conception, Marseille, France, 16Internal Medicine, Aix-Marseille Université, APHM, Marseille, France, 17CIML, Laboratoire d'Immunologie Conception AP-HM, Aix-Marseille université, Marseille, France

    Background/Purpose: IgG4-related disease (IgG4-RD) is associated with characteristic pathological changes including lymphoplasmocytic infiltration with abundant IgG4 positive plasma cells, storiform fibrosis and obliterative phlebitis. The…
  • Abstract Number: 1381 • 2015 ACR/ARHP Annual Meeting

    The Relationship Between Serum Cholinesterase, Number of Organ Involvement and Fibrotic Markers in Japanese Patients with IgG4-Related Disease

    Hirofumi Nishikawa1, Yoshinori Taniguchi1, Yoshiko Shimamura1, Kosuke Inoue1, Taro Horino1, Susumu Nishiyama2, Yasuhiko Yoshinaga2 and Yoshio Terada1, 1Kochi University, Nankoku, Japan, 2Kurashiki Medical Center, Kurashiki, Japan

    Background/Purpose: To evaluate the relationship between cholinesterase, number of organ involvement and serum fibrotic markers in Japanese patients with IgG4-related disease (IgG4-RD). Methods: The clinical…
  • « Previous Page
  • 1
  • …
  • 1960
  • 1961
  • 1962
  • 1963
  • 1964
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology